Aprea Therapeutics, Inc.
USD0.82
+0.03 (+3.67%)
CEO
Oren Gilad
IPO Date
2019-10-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.78
Prev. Close
$0.79
Day Low
$0.78
Day High
$0.82
52W Low
$0.55
52W High
$2.22
Market Cap
$0.01B
Volume
0.06M
| 12,555 |
| $0.73 |
| 17 Jun 2026 | Gruia Gabriela | director | A-Award | Acquired | 3,135 | $0.00 |
| 17 Jun 2026 | Gruia Gabriela | director | A-Award | Acquired | 12,555 | $0.73 |
| 17 Jun 2026 | Peters Richard | director | A-Award | Acquired | 3,135 | $0.00 |
| 17 Jun 2026 | Peters Richard | director | A-Award | Acquired | 12,555 | $0.73 |
| 17 Jun 2026 | HENNEMAN JOHN B III | director | A-Award | Acquired | 3,135 | $0.00 |
| 17 Jun 2026 | HENNEMAN JOHN B III | director | A-Award | Acquired | 12,555 | $0.73 |
| 17 Jun 2026 | BIZZARI JEAN-PIERRE | director | A-Award | Acquired | 3,135 | $0.00 |
| 17 Jun 2026 | BIZZARI JEAN-PIERRE | director | A-Award | Acquired | 12,555 | $0.73 |